Clinical trials
Phase 2 Dyslipidemias trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 1 |
| 2013 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2022 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Akcea Therapeutics | 3 |
| Pfizer | 3 |
| Bristol-Myers Squibb | 2 |
| University Health Network, Toronto | 2 |
| Amgen | 1 |
| Arrowhead Pharmaceuticals | 1 |
| AstraZeneca | 1 |
| Catabasis Pharmaceuticals | 1 |
| Eli Lilly and Company | 1 |
| Genentech, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dyslipidemias | 17 |
| Hyperlipidemias | 7 |
| Hypercholesterolemia | 5 |
| Hyperlipoproteinemias | 4 |
| Lipid Metabolism Disorders | 4 |
| Metabolic Diseases | 4 |
| Cardiovascular Diseases | 3 |
| Diabetes Mellitus, Type 2 | 2 |
| Hypertriglyceridemia | 2 |
| Acute Coronary Syndrome | 1 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.